Metformin is the mainstay therapy for type 2 diabetes (T2D) and many patients also take salicylate-based drugs [i.e., aspirin (ASA)] for cardioprotection. Metformin and salicylate both increase AMP-activated protein kinase (AMPK) activity but by distinct mechanisms, with metformin altering cellular adenylate charge (increasing AMP) and salicylate interacting directly at the AMPK β1 drug-binding site. AMPK activation by both drugs results in phosphorylation of ACC (acetyl-CoA carboxylase; P-ACC) and inhibition of acetyl-CoA carboxylase (ACC), the rate limiting enzyme controlling fatty acid synthesis (lipogenesis). We find doses of metformin and salicylate used clinically synergistically activate AMPK in vitro and in vivo, resulting in reduced liver lipogenesis, lower liver lipid levels and improved insulin sensitivity in mice. Synergism occurs in cell-free assays and is specific for the AMPK β1 subunit. These effects are also observed in primary human hepatocytes and patients with dysglycaemia exhibit additional improvements in a marker of insulin resistance (proinsulin) when treated with ASA and metformin compared with either drug alone. These data indicate that metformin–salicylate combination therapy may be efficacious for the treatment of non-alcoholic fatty liver disease (NAFLD) and T2D.
Skip Nav Destination
Article navigation
May 2015
- Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
Research Article|
May 05 2015
Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity
Rebecca J. Ford;
Rebecca J. Ford
*Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, 1280 Main St. W., Hamilton, Ontario, Canada L8N 3Z5
Search for other works by this author on:
Morgan D. Fullerton;
Morgan D. Fullerton
*Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, 1280 Main St. W., Hamilton, Ontario, Canada L8N 3Z5
Search for other works by this author on:
Stephen L. Pinkosky;
Stephen L. Pinkosky
*Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, 1280 Main St. W., Hamilton, Ontario, Canada L8N 3Z5
Search for other works by this author on:
Emily A. Day;
Emily A. Day
*Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, 1280 Main St. W., Hamilton, Ontario, Canada L8N 3Z5
Search for other works by this author on:
John W. Scott;
John W. Scott
†St. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, 41 Victoria Parade, Fitzroy, Vic 3065, Australia
Search for other works by this author on:
Jonathan S. Oakhill;
Jonathan S. Oakhill
†St. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, 41 Victoria Parade, Fitzroy, Vic 3065, Australia
Search for other works by this author on:
Adam L. Bujak;
Adam L. Bujak
*Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, 1280 Main St. W., Hamilton, Ontario, Canada L8N 3Z5
Search for other works by this author on:
Brennan K. Smith;
Brennan K. Smith
*Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, 1280 Main St. W., Hamilton, Ontario, Canada L8N 3Z5
Search for other works by this author on:
Justin D. Crane;
Justin D. Crane
*Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, 1280 Main St. W., Hamilton, Ontario, Canada L8N 3Z5
Search for other works by this author on:
Regje M. Blümer;
Regje M. Blümer
*Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, 1280 Main St. W., Hamilton, Ontario, Canada L8N 3Z5
Search for other works by this author on:
Katarina Marcinko;
Katarina Marcinko
*Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, 1280 Main St. W., Hamilton, Ontario, Canada L8N 3Z5
Search for other works by this author on:
Bruce E. Kemp;
Bruce E. Kemp
†St. Vincent's Institute of Medical Research and Department of Medicine, University of Melbourne, 41 Victoria Parade, Fitzroy, Vic 3065, Australia
Search for other works by this author on:
Hertzel C. Gerstein;
Hertzel C. Gerstein
*Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, 1280 Main St. W., Hamilton, Ontario, Canada L8N 3Z5
Search for other works by this author on:
Gregory R. Steinberg
Gregory R. Steinberg
1
*Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, 1280 Main St. W., Hamilton, Ontario, Canada L8N 3Z5
#x2021;Department of Biochemistry and Biomedical Sciences, McMaster University, 1280 Main St. W., Hamilton, Ontario, Canada L8N 3Z5
1To whom correspondence should be addressed (email gsteinberg@mcmaster.ca).
Search for other works by this author on:
Biochem J (2015) 468 (1): 125–132.
Article history
Received:
January 27 2015
Revision Received:
February 25 2015
Accepted:
March 05 2015
Accepted Manuscript online:
March 05 2015
Citation
Rebecca J. Ford, Morgan D. Fullerton, Stephen L. Pinkosky, Emily A. Day, John W. Scott, Jonathan S. Oakhill, Adam L. Bujak, Brennan K. Smith, Justin D. Crane, Regje M. Blümer, Katarina Marcinko, Bruce E. Kemp, Hertzel C. Gerstein, Gregory R. Steinberg; Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity. Biochem J 15 May 2015; 468 (1): 125–132. doi: https://doi.org/10.1042/BJ20150125
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.